Boathouse Capital is pleased to announce that it has completed an investment in Bryn Mawr Communications, a leader in omnichannel healthcare content, education, events, and medical communications for healthcare professionals in the eyecare/vision, dermatology/aesthetics, endovascular/cardiology, and neurology specialties. The investment from Boathouse will help accelerate the company’s growth within its existing markets as well as new specialties.
Bryn Mawr Communications is a trusted partner for medical device, biopharmaceutical, and life science that rely on its clinically relevant content and leading brands to engage with key opinion leaders across multiple therapeutic specialties. Founded in 2001, Bryn Mawr Communication owns some of the most popular brands for healthcare practitioners and key opinion leaders in the US and Europe, including Cataract & Refractive Surgery Today, Modern Optometry, Practical Dermatology, Endovascular Today, Cardiac Interventions Today, and Practical Neurology. The company also operates the largest educational video-based website in the vision field and recently launched the innovative Young MD Connect platform. In addition, BMC owns and produces multiple live and virtual meetings in the healthcare space.
Andrew Olsen, Partner, remarked, “Bryn Mawr Communications has a longstanding reputation as a thought leader and resource for healthcare practitioners, particularly in the large and growing specialties of medical vision and eyecare. We see significant growth opportunities in these specialties driven by demographics, product innovation, and new channels for communicating with healthcare providers and patients. We are excited to work with David and the Bryn Mawr Communications team and draw upon our experience in healthcare marketing and communications.”
David Cox, CEO said, “This investment represents Boathouse Capital’s fourth platform investment in outsourced biopharmaceutical and life science services. I’m thrilled to have an experienced capital provider on board as we enter our next phase of growth.”
About Us
Boathouse Capital is a Philadelphia-based private equity firm with $650 million of capital under management. We invest $5 million to $50 million of flexible capital in the form of debt and/or equity into high growth middle-market companies including SaaS/software, technology-enabled services and healthcare IT/services companies. Our sector-focused investment strategy is centered around partnering with management teams to create enduring value and position our companies for accelerated growth.
www.boathousecapital.com
The M&A market for healthcare companies continues to strengthen in 2022 ahead of projected increases in US capital gains taxes. There is unprecedented capital in market, the lowest interest rates in US history and strong acquirer motivations for high quality healthcare companies. Across the continuum of care, buyers and investors are looking for well established, profitable businesses and offering strong valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
